Pharmaceutical companies have already had the ability to develop FDA-approved cannabis drugs, but rescheduling removes several of the primary bureaucratic and financial hurdles that have slowed clinical research under Schedule I.
The double edge here is that it opens up the ability to expand research on cannabis, but also gives these same companies that have controlled that industry (and the drugs within) the same ability to control cannabis. They didn't legalize weed, they said "hey big pharma, now you can get your paws on this too."
You guys fans of Bayer? Pfizer? Because that's who is now going to be in your weed. Guess who has more money than 99% of cannabis growers and breeders that exist today? Pharma. Wait until they enter the genetic side of things.
This wasn't a win for cannabis. This isn't a win for home growers. This isn't a win for medical patients.
We're celebrating letting the lions into the lambs pen.